What Is the NICC Test?

The NICC test (often called a Non-Invasive Chromosomal Check) is a type of non-invasive prenatal test (NIPT Test). It analyses small fragments of your baby’s DNA—called cell-free fetal DNA (cffDNA)—that naturally circulate in the mother’s bloodstream during pregnancy.

By using advanced DNA analysis from a simple maternal blood draw, NICC estimates the likelihood (risk) of certain chromosomal conditions in the baby, without the procedure-related miscarriage risk associated with invasive tests like amniocentesis or chorionic villus sampling (CVS).

Who Should Consider NICC?

NICC can be helpful for many pregnancies, and is often recommended if any of the following apply:

• Maternal age 35 or older at delivery (advanced maternal age).
• Previous pregnancy affected by a chromosomal condition.
• Abnormal or uncertain findings on first-trimester screening or ultrasound.
• Family history of relevant genetic or chromosomal conditions.
• Parents seeking earlier, more informative screening with minimal risk.

Your clinician will assess your medical history, ultrasound findings, and preferences to determine whether NICC suits your situation.

What NICC Screens For

Panels vary by laboratory. Common targets include:

• Trisomy 21 (Down syndrome)
• Trisomy 18 (Edwards syndrome)
• Trisomy 13 (Patau syndrome)
• Sex chromosome conditions (e.g., Turner syndrome [Monosomy X], Klinefelter syndrome [XXY])
• Optional: Fetal sex reporting (on request)
• Optional (panel-dependent): Selected microdeletions

Accuracy & Limitations

NICC (NIPT Test) generally shows high sensitivity and specificity for common trisomies, especially Trisomy 21. However, as a screen, it can yield false positives or false negatives. Accuracy can be influenced by factors like fetal fraction (the proportion of fetal DNA in maternal blood), gestational age, maternal weight, and biological variation (e.g., confined placental mosaicism).

• High-risk ≠ diagnosis → confirm with amniocentesis/CVS.
• Low-risk ≠ zero risk → continue routine scans and care.
• Some conditions are not covered by NICC.

Your report may include analytical terms (e.g., “risk category,” “fetal fraction,” or “no call”). Your provider will interpret these in context with ultrasound and clinical findings.

Timing: When to Test

Most patients can take NICC from around 12 weeks’ gestation. Testing earlier than this may reduce fetal fraction and increase the chance of an inconclusive result. Many clinics coordinate NICC after the dating scan or alongside first-trimester care.

Turnaround time: Reports typically return in 10–14 working days, depending on lab workflow and logistics.

How to Prepare

• No fasting needed.
• Hydrate well before your appointment.
• Bring relevant medical history and current medications.
• Decide in advance if you wish to know fetal sex.
• Ask about panel options (e.g., inclusion of sex chromosomes or microdeletions).

Step-by-Step Process

1. Pre-test counselling: Review indications, benefits, and limits of NICC; confirm consent and panel choices.
2. Blood draw: A standard venous sample from your arm; no special prep required.
3. Laboratory analysis: Extraction of cffDNA and analysis using validated methods to evaluate chromosomal representation.
4. Quality checks: Ensuring fetal fraction and metrics meet thresholds to issue a result.
5. Reporting: Your clinician receives the report and will contact you to discuss outcomes and next steps.

Understanding Your Results

Inconclusive / No-Call

Sometimes the test cannot report (often due to low fetal fraction). Options include repeating the test, waiting to a later gestation, or considering alternative pathways based on ultrasound findings and clinical context.

Special Situations

• Twin pregnancies: Many panels support twins, but some features (e.g., individual sex reporting) may differ.
• IVF/Donor eggs: Usually eligible; disclose cycle details for accurate interpretation.
• Higher BMI: May reduce fetal fraction; timing and expectations can be adjusted.
• Translocations or parental chromosomal variants: Discuss with your clinician; targeted counselling may be needed.
• Vanishing twin/placental mosaicism: Can affect results—your provider will factor this into interpretation.

How NICC Compares to Other Options

Consent, Privacy & Ethics

• Informed consent: Understand what NICC can and cannot tell you before testing.
• Data privacy: Ask how your sample and data are stored, used, and for how long.
• Results preferences: Decide whether you want fetal sex information disclosed.
• Support: If results raise concerns, access genetic counselling and support services.